Companies: 10,795·Total market cap: $144.5T
TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc.

TFFPNASDAQHealthcare
$0.07
$-0.10(-60.05%)
Market Cap$288798
P/E Ratio—
52W High$11.0
52W Low$0.061
Overview

TFF Pharmaceuticals, Inc. (TFFP) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001733413 · TFFP · NASDAQ · as of Jun 9, 2026

Filing snapshot

317
Total Filings
EFFECT
Latest Form
2025-03-07
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001733413 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-03-28
Fiscal Year End
Mar 28, 2024
Accession No.
0001213900-24-027185
Primary Document
ea0201339-10k_tffpharma.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001733413 · Accession 0001213900-24-027185

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2024-11-20
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2025-03-06Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
EFFECTEFFECT
EFFECT
2025-03-07
View
EFFECTEFFECT
EFFECT
2025-03-07
View
EFFECTEFFECT
EFFECT
2025-03-07
View
EFFECTEFFECT
EFFECT
2025-03-07
View
2525
FORM 25
2025-03-06
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
2025-03-06
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
2025-03-06
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
2025-03-06
View
POS AMPOS AM
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
2025-03-06
View
POS AMPOS AM
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
2025-03-06
View
POS AMPOS AM
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
2025-03-06
View
POS AMPOS AM
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
2025-03-06
View
8-KCurrent Report
CURRENT REPORT
2025-03-06
View
DEFA14AProxy Statement (Additional)
DEFINITIVE ADDITIONAL MATERIALS
2025-02-04
View
8-KCurrent Report
CURRENT REPORT
2025-02-03
View
Showing 1–15 of 210 filingsForm 4 / 144 hidden· 317 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001733413  |  Exchange: NASDAQ · Healthcare

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) has submitted 317 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001733413, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is TFF Pharmaceuticals, Inc.'s most comprehensive regulatory disclosure. The most recent TFF Pharmaceuticals, Inc. 10-K was filed on 2024-03-28 for fiscal year ending 2024. Historical TFFP 10-K annual reports are available from 2018 through 2024.

Investors researching TFF Pharmaceuticals, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
LFLY SEC Filings →LSB SEC Filings →PHIO SEC Filings →OSA SEC Filings →SEEL SEC Filings →VIRI SEC Filings →KERN SEC Filings →BLPH SEC Filings →
→ TFFP Financials→ TFFP Earnings→ TFFP Insider Trades

Frequently Asked Questions

TFFP SEC Filings · 8 questions

TFF Pharmaceuticals, Inc. (TFFP) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 317 filings and access original documents at no cost. TFF Pharmaceuticals, Inc.'s CIK is 0001733413.

TFFP SEC filingsTFF Pharmaceuticals, Inc. SEC documentsfind TFFP 10-K